Protect your workforce

Protect your business

Rapid Saliva Protein Tests offer results in 15 minutes

Price per Unit £29.99

Rapid Saliva Protein Test

  • Result on the spot in 15 mins
  • Simple to take
  • Saliva sample using lateral flow cassette
  • Non-invasive testing
  • Detects infection earlier than blood antibody tests
  • Triage model to reduce pressure on PCR testing
  • Only £29.99
  • Verify test results with digital passport, for travel and work purposes
  • CE marked and registered with the MHRA

Get in touch today

For more information about our business solutions, fill in the form below:

*Required field

How the test works

The Rapid Saliva Protein Test (RSPT), from Medusa 19, provides results on the spot in 15 minutes. It is a lateral flow saliva test to indicate the immune response to infection particularly in patients who do not know they have an active SARS-CoV-2 infection and have no specific symptoms.

The Rapid Saliva Protein Test (RSPT) is a simple, non-invasive, on the spot test indicating the immune response to infection from SARS-CoV-2, the virus underlying COVID-19.

Watch our video to learn how to take the test.

Independent clinical trials demonstrated the following:

About Medusa 19

With the continued impact of COVID-19 on businesses, organisations and individuals, boohoo co-founders and entrepreneurs Richard Hughes and Mahmud Kamani established Medusa19 with the objective of rapidly building a point-of-care medical diagnostics business, ensuring employee safety and business continuity, ‘Rebuilding Confidence’ in businesses and the economy.

Richard Hughes & Christian Stephenson

Get in touch

Leave your details below and we’ll contact you to discuss your business testing requirements

*Required field

Case Studies

Supporting global recovery

Medusa 19 is undergoing a landmark clinical trial with the public universities in Madrid to test up to 1,500 students and professors.

Ignacio Aguado, Vice President of Madrid, said:

“The rapid saliva protein test from Medusa 19 could be a turning point in the detection of COVID-19. It may be the first self-diagnosis test that can be used at home and that would be revolutionary.”

In the news